Blog Archives

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.


Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease

D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.


Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor

A. Espay, M. Edwards, G. Oggioni, N. Phielipp, B. Cox, H. Gonzalez-Usigli, C. Pecina, D. Heldman, J. Mishra, A. Lang Parkinsonism Relat Disord. 2014;20(6):647–50.


PRESS RELEASE: Kinesia ProView Launches to Visualize Parkinson’s Symptom Response to Deep Brain Stimulation Programming

VIEW PRESS RELEASE [PDF] 15 MAY 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView™ [ http://www.glneurotech.com/kinesia/proview/index.php ] to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson’s disease. Kinesia ProView provides a standardized platform to quantitatively assess

Read more ›


Tremor retrainment as therapeutic strategy for patients with psychogenic tremor: A proof-of-concept study

A. Espay, G. Oggioni, M. Edwards, N. Phielipp, H. Gonzalez-Usigli, C. Pecina, D. Heldman, J. Mishra, A. Lang 17th International Congress of Parkinson’s Disease and Movement Disorders. Sydney, Australia, 2013


Active-Assisted Cycling Improves Tremor and Bradykinesia in Parkinson’s Disease

A. Ridgel, C. Peacock, E. Fickes, C. Kim Arch Phys Med Rehabil. 2012 Nov;93(11):2049-54


PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS)

Read more ›


PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  These intellectual property claims

Read more ›


PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health’s SBIR program. Each project is focused on developing and

Read more ›